GlaxoSmithKline plc (LON:GSK)‘s stock had its “buy” rating reissued by Citigroup Inc. in a research report issued on Friday.

Other analysts have also issued research reports about the company. Goldman Sachs Group Inc. set a GBX 1,800 ($23.50) target price on GlaxoSmithKline plc and gave the company a “buy” rating in a report on Friday, June 3rd. Beaufort Securities reaffirmed a “buy” rating on shares of GlaxoSmithKline plc in a report on Friday, June 3rd. Shore Capital reissued a “buy” rating on shares of GlaxoSmithKline plc in a report on Wednesday, June 1st. Jefferies Group raised GlaxoSmithKline plc to a “buy” rating and lifted their price objective for the stock from GBX 1,650 ($21.54) to GBX 2,000 ($26.11) in a report on Thursday, July 14th. Finally, Bryan, Garnier & Co reissued a “buy” rating on shares of GlaxoSmithKline plc in a report on Thursday, July 28th. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and eight have assigned a buy rating to the company. GlaxoSmithKline plc currently has an average rating of “Hold” and a consensus target price of GBX 1,676.44 ($21.88).

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

GlaxoSmithKline plc (LON:GSK) opened at 1646.53 on Friday. GlaxoSmithKline plc has a one year low of GBX 1,227.50 and a one year high of GBX 1,716.50. The stock’s 50 day moving average price is GBX 1,652.88 and its 200-day moving average price is GBX 1,532.04. The firm’s market capitalization is GBX 80.04 billion.

The business also recently disclosed a dividend, which will be paid on Thursday, October 13th. Investors of record on Thursday, August 11th will be issued a GBX 19 ($0.25) dividend. The ex-dividend date of this dividend is Thursday, August 11th. This represents a yield of 1.12%.

In related news, insider Slaoui,Moncef acquired 28 shares of the company’s stock in a transaction that occurred on Friday, August 12th. The stock was acquired at an average price of GBX 2,208 ($28.82) per share, for a total transaction of £618.24 ($807.00). Also, insider Witty,Sir Andrew P sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($22.10), for a total value of £169,300 ($220,989.43).

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.